.

Ultragenyx Pharmaceutical reported $230.94M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 168.21M 60.27M
Agios Pharmaceuticals AGIO:US $ 100.52M 1.24M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Aptinyx Inc APTX:US $ 17.1M 2.27M
Biocryst Pharmaceuticals BCRX:US $ 100.25M 374K
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Epizyme EPZM:US $ 57.33M 2.29M
Esperion Therapeutics ESPR:US $ 71.22M 9.39M
Insmed INSM:US $ 153.54M 10.6M
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
Karyopharm Therapeutics KPTI:US $ 82.59M 331K
Kyowa Hakko Kirin 4151:JP 75.81B 5.61B
Macrogenics MGNX:US $ 67.82M 9.92M
Mirati Therapeutics MRTX:US $ 182.57M 2.36M
Moderna Inc MRNA:US 2.3B 463M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Ptc Therapeutics PTCT:US $ 257.89M 22.63M
Puma Biotechnology PBYI:US $ 47.52M 1.01M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
Vital Therapies VTL:US $ 20.61M 825K
Xoma XOMA:US $ 5.75M 578K